National meeting about advanced molecular cancer diagnostics
Tuesday the 11th of June oncologist and pathologist from all the University Hospitals in Norway gathered at the Radiumhospital to discuss implementation of personalized medicine in cancer treatment.
The meeting was organized by the Division of Cancer Medicine at OUS to highlight the needs and challenges related to the advanced molecular diagnostics needed for implementation of personalized medicine in both clinic practice and clinical trials.
Published in Level 2 journals, first or last author from Oslo University Hospital.
Atar D, Vandenbriele C, Agewall S, Gigante B, Goette A, Gorog DA, Holme PA, Krychtiuk KA, Rocca B, Siller-Matula JM, Valgimigli M, Rubboli A, Klamroth R(2025) Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy Eur Heart J Cardiovasc Pharmacother(in press) DOI 10.1093/ehjcvp/pvaf006, PubMed 40145128
Olstad EW, Nordeng H, Bjørk MH, Selmer KK, Gervin K(2025) Agreement Between Parental Self-Reported Antiseizure Medication Use and Dispensed Prescription Records From a National Prescription Database Pharmacoepidemiol Drug Saf, 34(4), e70139 DOI 10.1002/pds.70139, PubMed 40134051
Bergholtz H, Norum JH, Lien TG, Skrede ML, Garred Ø, Sørlie T(2025) B cells and energy metabolism in HER2-positive DCIS: insights into breast cancer progression from spatial-omics analyses Breast Cancer Res, 27(1), 44 DOI 10.1186/s13058-025-01990-2, PubMed 40119362